Dimethylformamide → HCID 57932965, compound
Reaction equation
Br[C:2]1[S:6][C:5]([C:7]2[N:11]3[N:12]=[C:13]([CH3:21])[CH:14]=[C:15]([CH:16]([CH2:19][CH3:20])[CH2:17][CH3:18])[C:10]3=[N:9][C:8]=2[CH3:22])=[C:4]([CH3:23])[CH:3]=1.[CH3:24][N:25](C=O)C>CCOC(C)=O.[C-]#N.[C-]#N.[Zn+2].C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:17]([CH:16]([C:15]1[C:10]2[N:11]([C:7]([C:5]3[S:6][C:2]([C:24]#[N:25])=[CH:3][C:4]=3[CH3:23])=[C:8]([CH3:22])[N:9]=2)[N:12]=[C:13]([CH3:21])[CH:14]=1)[CH2:19][CH3:20])[CH3:18]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 3
Procedure
A solution of 3-(5-bromo-3-methyl-thiophen-2-yl)-8-(1-ethyl-propyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine (0.50 g, 1.28 mmol), DMF (5 mL), and Zn(CN)2 (0.090 g, 0.76 mmol) is degassed with nitrogen for 15 minutes. Pd(PPh3)4 (0.74 g, 0.064 mmol) and the solution heated at 100° C. overnight. The solution is diluted with EtOAc (50 mL), washed with 2 M NH4OH (2×30 mL), brine (30 mL), dried over MgSO4, filtered and concentrated. Purified by ISCO column chromatography (15%-20% EtOAc/hexane gradient) furnish the title compound (0.39 g, 1.15 mmol, 91%). 1H NMR (CDCl3), δ 0.87 (t, J=7.5 Hz, 6H), 1.74-1.91 (m, 4H), 2.15 (s, 3H), 2.46 (s, 3H), 2.51 (s, 3H), 3.26-3.34 (m, 1H), 6.72 (s, 1H), 7.53 (s, 1H). LC/MS (m/z): calcd. for C19H22N4S (M+H)+: 339.6; found: 339.2.
Workup
- washwashed with 2 M NH4OH (2×30 mL), brine (30 mL)
- dry with materialdried over MgSO4
- filtrationfiltered
- concentrationconcentrated
- customPurified by ISCO column chromatography (15%-20% EtOAc/hexane gradient)
Sources & evidence
- ORD record
- ord-df439cfe1d974a9796afdd453588b3ae
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07612067B2
Reaction notes
Loading…